Experience of a Performance-Based Risk-Sharing Arrangement for the Treatment of Rheumatoid Arthritis With Certolizumab Pegol.
Value Health Reg Issues
; 21: 201-204, 2020 May.
Article
in En
| MEDLINE
| ID: mdl-32199257
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Patients
/
Arthritis, Rheumatoid
/
Risk Sharing, Financial
/
Certolizumab Pegol
Type of study:
Etiology_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Value Health Reg Issues
Year:
2020
Document type:
Article
Country of publication:
United States